Article: PTH appropriate for a select few patients with bone loss.(Metabolic Disorders)(parathyroid hormone)

SNOWMASS, COLO. -- The current evidence suggests it is a very small group of individuals with low bone density who should be treated with parathyroid hormone, Dr. Lenore Buckley said at a symposium sponsored by the American College of Rheumatology.

Probably the only patients who are proper candidates for parathyroid hormone (PTH) therapy, according to a recent cost-effectiveness analysis, are those patients who have an extremely low T score, below -3.5, and who are at least 70 years old or have had a vertebral fracture, said Dr. Buckley, a professor of internal medicine at Virginia Commonwealth University, Richmond.

The cost-effectiveness analysis to ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!